Literature DB >> 12507885

Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.

Michael Bacher1, Jörg Schrader, Nancy Thompson, Karen Kuschela, Diethard Gemsa, Gérard Waeber, Jürgen Schlegel.   

Abstract

Glioblastoma multiforme (GBM) is the most malignant variant of human glial tumors. A prominent feature of this tumor is the occurrence of necrosis and vascular proliferation. The regulation of glial neovascularization is still poorly understood and the characterization of factors involved in this process is of major clinical interest. Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine released by leukocytes and by a variety of cells outside of the immune system. Recent work has shown that MIF may function to regulate cellular differentiation and proliferation in normal and tumor-derived cell lines, and may also contribute to the neovascularization of tumors. Our immunohistological analysis of MIF distribution in GBM tissues revealed the strong MIF protein accumulation in close association with necrotic areas and in tumor cells surrounding blood vessels. In addition, MIF expression was frequently associated with the presence of the tumor-suppressor gene p53. To substantiate the concept that MIF might be involved in the regulation of angiogenesis in GBM, we analyzed the MIF gene and protein expression under hypoxic and hypoglycemic stress conditions in vitro. Northern blot analysis showed a clear increase of MIF mRNA after hypoxia and hypoglycemia. We could also demonstrate that the increase of MIF transcripts on hypoxic stress can be explained by a profound transcriptional activation of the MIF gene. In parallel to the increase of MIF transcripts, we observed a significant rise in extracellular MIF protein on angiogenic stimulation. The data of our preliminary study suggest that the up-regulation of MIF expression during hypoxic and hypoglycemic stress might play a critical role for the neovascularization of glial tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507885      PMCID: PMC1851138          DOI: 10.1016/S0002-9440(10)63793-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Primary and secondary glioblastomas: from concept to clinical diagnosis.

Authors:  P Kleihues; H Ohgaki
Journal:  Neuro Oncol       Date:  1999-01       Impact factor: 12.300

2.  Macrophage migration inhibitory factor production by Leydig cells: evidence for a role in the regulation of testicular function.

Authors:  A Meinhardt; M Bacher; J R McFarlane; C N Metz; J Seitz; M P Hedger; D M de Kretser; R Bucala
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

3.  An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.

Authors:  J Chesney; C Metz; M Bacher; T Peng; A Meinhardt; R Bucala
Journal:  Mol Med       Date:  1999-03       Impact factor: 6.354

4.  De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.

Authors:  H Y Lan; W Mu; N Yang; A Meinhardt; D J Nikolic-Paterson; Y Y Ng; M Bacher; R C Atkins; R Bucala
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 5.  MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response.

Authors:  R Bucala
Journal:  FASEB J       Date:  1996-12       Impact factor: 5.191

Review 6.  The p53 gene and its role in human brain tumors.

Authors:  O Bögler; H J Huang; P Kleihues; W K Cavenee
Journal:  Glia       Date:  1995-11       Impact factor: 7.452

7.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

9.  Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization.

Authors:  T Shimizu; A Ohkawara; J Nishihira; W Sakamoto
Journal:  FEBS Lett       Date:  1996-03-04       Impact factor: 4.124

10.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

View more
  42 in total

Review 1.  Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.

Authors:  Terri S Armstrong; Patrick Y Wen; Mark R Gilbert; David Schiff
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

2.  Oxygen regulation of macrophage migration inhibitory factor in human placenta.

Authors:  Francesca Ietta; Yuanhong Wu; Roberta Romagnoli; Nima Soleymanlou; Barbara Orsini; Stacy Zamudio; Luana Paulesu; Isabella Caniggia
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-29       Impact factor: 4.310

3.  Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.

Authors:  Chia-Tung Shun; Jaw-Town Lin; Shih-Pei Huang; Min-Tsan Lin; Ming-Shiang Wu
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

4.  Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Authors:  Xiao-Bing Wang; Xiao-Ying Tian; Yang Li; Bin Li; Zhi Li
Journal:  J Neurooncol       Date:  2011-07-03       Impact factor: 4.130

5.  Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance.

Authors:  Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Paul A Decker; Bruce W Morlan; Wenting Wu; Karla V Ballman; Caterina Giannini; Jann N Sarkaria
Journal:  J Neurooncol       Date:  2010-05-05       Impact factor: 4.130

6.  Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization.

Authors:  Millicent Winner; Albert C Koong; Beatriz E Rendon; Wayne Zundel; Robert A Mitchell
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

7.  Glioma-derived macrophage migration inhibitory factor (MIF) promotes mast cell recruitment in a STAT5-dependent manner.

Authors:  Jelena Põlajeva; Tobias Bergström; Per-Henrik Edqvist; Anders Lundequist; Anna Sjösten; Gunnar Nilsson; Anja Smits; Michael Bergqvist; Fredrik Pontén; Bengt Westermark; Gunnar Pejler; Karin Forsberg Nilsson; Elena Tchougounova
Journal:  Mol Oncol       Date:  2013-09-18       Impact factor: 6.603

8.  Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.

Authors:  Ilkyu Han; Mi Ra Lee; Kwang Woo Nam; Joo Han Oh; Kyung Chul Moon; Han-Soo Kim
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 9.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

10.  Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.

Authors:  Jörg Schrader; Oliver Deuster; Birgit Rinn; Martina Schulz; Andreas Kautz; Richard Dodel; Bernhard Meyer; Yousef Al-Abed; Karthikeyan Balakrishnan; Jens P Reese; Michael Bacher
Journal:  BMC Cancer       Date:  2009-12-28       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.